A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin-Reference-Cited by-同舟云学术

A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin

Published:2021-12 Issue: Volume:196 Page:105208
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Vanderlinden Evelien^ORCID,Marchand Arnaud^ORCID,Van Berwaer Ria,van Dam Wim,Arzel Philippe,Klaassen Hugo,Persoons Leentje^ORCID,Chaltin Patrick,Naesens Lieve^ORCID

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference30 articles.

1. Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection;Amorim;J. Virol.,2013

2. Introduction of a fluorine atom at C3 of 3-deazauridine shifts its antimetabolic activity from inhibition of CTP synthetase to inhibition of orotidylate decarboxylase, an early event in the de novo pyrimidine nucleotide biosynthesis pathway;Balzarini;J. Biol. Chem.,2012

3. Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors;Chau;Cancer Res.,2014

4. Antivirals and antiviral strategies;De Clercq;Nat. Rev. Microbiol.,2004

5. The burden of influenza B: a structured literature review;Glezen;Am. J. Publ. Health,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modular Biomimetic Strategy Enables Discovery and SAR Exploration of Oxime Macrocycles as Influenza A Virus (H1N1) Inhibitors;Journal of Medicinal Chemistry;2024-05-13

2. Polyethylene Glycol-Modified Cationic Liposome as a Promising Nano Spray for Acute Pneumonia Treatment;Polymers;2024-05-12

3. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses;European Journal of Medicinal Chemistry;2024-02

4. LC–MS/MS separation and quantitation of ribavirin in chicken and comparison of different mass spectrometric platforms;BMC Chemistry;2023-08-07

5. The synergy between nucleotide biosynthesis inhibitors and antiviral nucleosides: New opportunities against viral infections?;Archiv der Pharmazie;2022-09-19